These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9375978)

  • 21. Block of Ca(2+)-channels by alpha-endosulphine inhibits insulin release.
    Virsolvy A; Smith P; Bertrand G; Gros L; Héron L; Salazar G; Puech R; Bataille D
    Br J Pharmacol; 2002 Apr; 135(7):1810-8. PubMed ID: 11934823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the imidazoline binding site ligands, idazoxan and efaroxan, on the viability of insulin-secreting BRIN-BD11 cells.
    Gao H; Mourtada M; Morgan NG
    JOP; 2003 May; 4(3):117-24. PubMed ID: 12743417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucose-induced insulin secretion is potentiated by a new imidazoline compound.
    Mest HJ; Raap A; Schloos J; Treinies I; Paal M; Giese U; Koivisto V
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jul; 364(1):47-52. PubMed ID: 11485038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterisation of new efaroxan derivatives for use in purification of imidazoline-binding sites.
    Chan SL; Pallett AL; Clews J; Ramsden CA; Chapman JC; Kane C; Dunne MJ; Morgan NG
    Eur J Pharmacol; 1998 Aug; 355(1):67-76. PubMed ID: 9754940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agmatine is not a good candidate as endogenous ligand for imidazoline sites of pancreatic B cells and vascular bed.
    Berdeu D; Puech R; Loubatières-Mariani MM; Bertrand G
    Eur J Pharmacol; 1996 Jul; 308(3):301-4. PubMed ID: 8858303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of insulin secretion in clonal BRIN-BD11 cells by the imidazoline derivatives KU14r and RX801080.
    Ball AJ; Flatt PR; McClenaghan NH
    Pharmacol Res; 2000 Dec; 42(6):575-9. PubMed ID: 11058411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clotrimazole and efaroxan inhibit red cell Gardos channel independently of imidazoline I1 and I2 binding sites.
    Coupry I; Armsby CC; Alper SL; Brugnara C; Parini A
    Eur J Pharmacol; 1996 Jan; 295(1):109-12. PubMed ID: 8925867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two generations of insulinotropic imidazoline compounds.
    Efendic S; Efanov AM; Berggren PO; Zaitsev SV
    Diabetes; 2002 Dec; 51 Suppl 3():S448-54. PubMed ID: 12475789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sigma receptor ligands and imidazoline secretagogues mediate their insulin secretory effects by activating distinct receptor systems in isolated islets.
    Chan SL; Morgan NG
    Eur J Pharmacol; 1998 Jun; 350(2-3):267-72. PubMed ID: 9696417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterisation of the insulinotropic activity of an aqueous extract of Gymnema sylvestre in mouse beta-cells and human islets of Langerhans.
    Liu B; Asare-Anane H; Al-Romaiyan A; Huang G; Amiel SA; Jones PM; Persaud SJ
    Cell Physiol Biochem; 2009; 23(1-3):125-32. PubMed ID: 19255507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that the ability of imidazoline compounds to stimulate insulin secretion is not due to interaction with sigma receptors.
    Chan SL; Pallett AL; Clews J; Ramsden CA; Morgan NG
    Eur J Pharmacol; 1997 Apr; 323(2-3):241-4. PubMed ID: 9128845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel I
    Tesfai J; Crane L; Baziard-Mouysset G; Edwards LP
    J Diabetes Metab; 2012 Apr; 3(3):. PubMed ID: 27429837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monomeric G-protein, Rhes, is not an imidazoline-regulated protein in pancreatic beta-cells.
    Sharoyko VV; Zaitseva II; Varsanyi M; Portwood N; Leibiger B; Leibiger I; Berggren PO; Efendić S; Zaitsev SV
    Biochem Biophys Res Commun; 2005 Dec; 338(3):1455-9. PubMed ID: 16277977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation of insulin secretion by the imidazoline alpha 2-adrenoceptor antagonist efaroxan is mediated by a novel, stereoselective, binding site.
    Chan SL; Brown CA; Morgan NG
    Eur J Pharmacol; 1993 Jan; 230(3):375-8. PubMed ID: 8095024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of morin-induced insulin secretion in cultured pancreatic cells.
    Lin MH; Hsu CC; Lin J; Cheng JT; Wu MC
    Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1254-1262. PubMed ID: 28699234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effects of efaroxan and beta-carbolines on the secretory activity of rodent and human beta cells.
    Morgan NG; Cooper EJ; Squires PE; Hills CE; Parker CA; Hudson AL
    Ann N Y Acad Sci; 2003 Dec; 1009():167-74. PubMed ID: 15028583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The imidazoline derivative calmidazolium inhibits voltage-gated Ca(2+)-channels and insulin release but has no effect on the phospholipase C system in insulin producing RINm5F-cells.
    Kindmark H; Köhler M; Gerwins P; Larsson O; Khan A; Wahl MA; Berggren PO
    Biosci Rep; 1994 Jun; 14(3):145-58. PubMed ID: 7833453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imidazolines and pancreatic hormone secretion.
    Morgan NG; Chan SL; Mourtada M; Monks LK; Ramsden CA
    Ann N Y Acad Sci; 1999 Jun; 881():217-28. PubMed ID: 10415920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissection of mechanisms that account for imidazoline-induced lowering of blood glucose in mice.
    Stadlbauer K; Lehner Z; Stamenkovic N; Rustenbeck I; Surman L; Luger A; Fürnsinn C
    Eur J Pharmacol; 2014 Oct; 741():178-85. PubMed ID: 25149664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreatic beta-cell-to-beta-cell interactions are required for integrated responses to nutrient stimuli: enhanced Ca2+ and insulin secretory responses of MIN6 pseudoislets.
    Hauge-Evans AC; Squires PE; Persaud SJ; Jones PM
    Diabetes; 1999 Jul; 48(7):1402-8. PubMed ID: 10389845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.